Paper41007745
Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy.
Xenos D and 3 others. Biomedicines, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy. Papers, record 41007745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interventional Oncology for Colorectal Liver Metastases: From Local Cure to Salvage Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed |
Source NIH RePORTER
References205
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21514841 | CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. | J Vasc Interv Radiol | 2011 | https://conductscience.org/library/papers/21514841 | PubMed |
| 2 | 25351506 | Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. | Eur J Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/25351506 | PubMed |
| 3 | 11843249 | Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. | Ann Oncol | 2001 | https://conductscience.org/library/papers/11843249 | PubMed |
| 4 | 39745670 | Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90 Y Radiation Segmentectomy of Colorectal Liver Metastases. | Clin Nucl Med | 2025 | https://conductscience.org/library/papers/39745670 | PubMed |
| 5 | 12044059 | Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit. | Neoplasma | 2002 | https://conductscience.org/library/papers/12044059 | PubMed |
| 6 | 34342018 | A novel use of biomechanical model-based deformable image registration (DIR) for assessing colorectal liver metastases ablation outcomes. | Med Phys | 2021 | https://conductscience.org/library/papers/34342018 | PubMed |
| 7 | 25086245 | Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. | Med Sci Monit | 2014 | https://conductscience.org/library/papers/25086245 | PubMed |
| 8 | 33767862 | Prognostic factors of survival in stage IV colorectal cancer with synchronous liver metastasis: Negative effect of the KRAS mutation. | Mol Clin Oncol | 2021 | https://conductscience.org/library/papers/33767862 | PubMed |
| 9 | 20567019 | Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20567019 | PubMed |
| 10 | 33741643 | Dose-Response and Dose-Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer. | J Nucl Med | 2021 | https://conductscience.org/library/papers/33741643 | PubMed |
| 11 | 34199556 | Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34199556 | PubMed |
| 12 | 39848272 | Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. | Lancet Oncol | 2025 | https://conductscience.org/library/papers/39848272 | PubMed |
| 13 | 39604694 | Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case Series. | Cardiovasc Intervent Radiol | 2025 | https://conductscience.org/library/papers/39604694 | PubMed |
| 14 | 29755770 | Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases. | J Gastrointest Oncol | 2018 | https://conductscience.org/library/papers/29755770 | PubMed |
| 15 | 24906565 | Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24906565 | PubMed |
| 16 | 27384594 | Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. | AJR Am J Roentgenol | 2016 | https://conductscience.org/library/papers/27384594 | PubMed |
| 17 | 39225612 | The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors. | Radiology | 2024 | https://conductscience.org/library/papers/39225612 | PubMed |
| 18 | 10861420 | Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. | Cancer | 2000 | https://conductscience.org/library/papers/10861420 | PubMed |
| 19 | 23670568 | Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. | Cardiovasc Intervent Radiol | 2014 | https://conductscience.org/library/papers/23670568 | PubMed |
| 20 | 22199334 | Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. | Anticancer Res | 2011 | https://conductscience.org/library/papers/22199334 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794898 | Histotripsy Outcomes for Primary and Metastatic Hepatic Disease. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794898 | PubMed |
| 42724862 | A SEER based SHAP interpretable prognostic nomogram for overall survival in surgically treated patients with colorectal cancer and synchronous liver metastasis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724862 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007745
GET https://conductscience.org/api/papers/v1/41007745/references?page=2